Working Paper Article Version 1 This version is not peer-reviewed

Marine Bacteria from Rocas Atoll: A Promising Biotechnological Resource

Version 1 : Received: 17 October 2019 / Approved: 19 October 2019 / Online: 19 October 2019 (02:01:18 CEST)

A peer-reviewed article of this Preprint also exists.

Velasco-Alzate, K.Y.; Bauermeister, A.; Tangerina, M.M.P.; Lotufo, T.M.C.; Ferreira, M.J.P.; Jimenez, P.C.; Padilla, G.; Lopes, N.P.; Costa-Lotufo, L.V. Marine Bacteria from Rocas Atoll as a Rich Source of Pharmacologically Active Compounds. Mar. Drugs 2019, 17, 671. Velasco-Alzate, K.Y.; Bauermeister, A.; Tangerina, M.M.P.; Lotufo, T.M.C.; Ferreira, M.J.P.; Jimenez, P.C.; Padilla, G.; Lopes, N.P.; Costa-Lotufo, L.V. Marine Bacteria from Rocas Atoll as a Rich Source of Pharmacologically Active Compounds. Mar. Drugs 2019, 17, 671.

Abstract

Rocas Atoll is a unique environment in the Equatorial Atlantic Ocean, hosting a large number of endemic species and studies on the chemical diversity emerging from this biota are rather scarce. Therefore, the present work aims to assess the metabolomic diversity and pharmacological potential of the microbiota from Rocas Atoll. A total of 76 bacteria were isolated and cultured in liquid culture media to obtain crude extracts. About one third (34%) of these extracts were considered cytotoxic against human colon adenocarcinoma HCT-116 cell line. 16S rRNA gene sequencing analysis revealed that the bacteria producing cytotoxic extracts are mainly from the Actinobacteria phylum, including Streptomyces, Salinispora, Nocardiopsis and Brevibacterium genera, and in a smaller proportion from Firmicutes phylum (Bacillus). The search in the GNPS spectral library unveiled a high chemodiversity being produced by these bacteria, including rifamycins, antimycins, desferrioxamines, ferrioxamines, surfactins, surugamides, staurosporine and saliniketals, along with several unidentified compounds. Using an original approach, molecular network successfully highlighted groups of compounds responsible for the cytotoxicity of crude extracts. DEREPLICATOR+, a recently developed in silico tool (GNPS), allowed the identification of derivatives of the macrolide novonestimycin, as the cytotoxic compounds into the extracts produced by Streptomyces BRB-298 and BRB-302. Overall, these results highlighted the pharmacological potential of bacteria from this singular Atoll.

Keywords

secondary metabolites; microbial diversity; metabolomics; molecular network; marine bacteria

Subject

Chemistry and Materials Science, Organic Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.